Authors: RUSTHOVEN JJ QUIRT IC ISCOE NA MCCULLOCH PB JAMES KW LOHMANN RC JENSEN J BURDETTERADOUX S BODURTHA AJ SILVER HKB VERMA S ARMITAGE GR ZEE B BENNETT K HEDLEY D FINE S MYERS R KING M MERTENS W TAYLOR M CANO P MALIK S VERGIDIS D SHORE S DUDGEON D SMYLIE M WILSON K KNOWLING M SAMOSH M GIESBRECHT J HUAN S SKILLINGS J GREGG R BELANGER K POLLAK M LATREILLE J BATIST G BOOS G GRUNER P HINGS I LOUTFI A THIRLWELL M TRUDEAU M JOLIVIT J AYOUB J CHARPENTIER D CLEMENT S YELLE L BELANGER D SHIBATA H

Citation: Jj. Rusthoven et al., RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL COMPARING THE RESPONSE RATES OF CARMUSTINE, DACARBAZINE, AND CISPLATIN WITH AND WITHOUT TAMOXIFEN IN PATIENTS WITH METASTATIC MELANOMA, Journal of clinical oncology, 14(7), 1996, pp. 2083-2090

Authors: HALMAY D HOLLINGSWORTH L LAMONTAGNE J THIRLWELL M

Citation: D. Halmay et al., DEVELOPMENT OF A VOLUNTEER ONCOLOGY PROGRAM IN A UNIVERSITY TERTIARY CARE HOSPITAL, Journal of palliative care, 11(4), 1995, pp. 64-64

Authors: BABUL N DHALIWAL H SLOAN P ARKINSTALL W THIRLWELL M HARSANYI Z DARKE A

Citation: N. Babul et al., ANALGESIC EFFICACY AND SAFETY OF CONTROLLED-RELEASE CODEINE AND PLACEBO IN CANCER PAIN, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 137-137

Authors: BABUL N HAGEN N THIRLWELL M DHALIWAL H HARSANYI Z DARKE A

Citation: N. Babul et al., STEADY-STATE DISPOSITION OF HYDROMORPHONE AND HYDROMORPHONE-3-GLUCURONIDE IN CANCER-PATIENTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 165-165

Authors: CHIAROTTO J THIRLWELL M TRUDEAU M SKELTON J BOOS G VIALLET J

Citation: J. Chiarotto et al., PHASE-I-II TRIAL OF AN UNCONVENTIONAL AGENT, POLYERGA, IN PATIENTS WITH ADVANCED CANCER, Clinical research, 42(1), 1994, pp. 10000104-10000104

Authors: HAYS H HAGEN N THIRLWELL M DHALIWAL H BABUL N HARSANYI Z DARKE AC

Citation: H. Hays et al., COMPARATIVE CLINICAL EFFICACY AND SAFETY OF IMMEDIATE-RELEASE AND CONTROLLED-RELEASE HYDROMORPHONE FOR CHRONIC SEVERE CANCER PAIN, Cancer, 74(6), 1994, pp. 1808-1816